<<MNTA has more than enough money to spend on generic Copaxone and the spend required is probably a lot less than you thin>>
I was thinking the same thing. The Copaxone NDA was filed more than two years ago, I assume litigatiion costs are not being funded by MNTA. So how much spending is there at this point?
Market Data 
Markets 
AI
